Bayer’s in-house programmatic benefits: 10x the reach and $10 million in savings

Stephen Whiteside

Bayer, the pharmaceutical company, is bringing programmatic advertising in-house through a two-year program that scales back agency involvement in this discipline over time.

Bayer, the pharmaceutical giant, wants an in-house team to handle the planning, strategy, buying, and execution of its programmatic advertising by 2020.

Josh Palau, vp/digital strategy and platforms at the Whippany, New Jersey-based company, is tasked with...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today